Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06626022 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.

Study acronym: MUSIC-Screen
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria expanded, about 9 words
    • Site details revised at 2 of 9 sites
    • Publications: details revised at 1 of 1 entry
  2. Site details revised at 1 of 9 sitesv10
  3. Study sites: 7 to 9v9
  4. Study sites: 6 to 7v8
  5. Study sites: 5 to 6v7
Show 5 earlier versionsHide 5 earlier versions
  1. Study sites: 4 to 5v6
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Apr 15, 2025 to May 8, 2025
    • Site details revised at 4 of 4 sites
    v5
  3. Start date: Feb 15, 2025 to Apr 15, 2025v4
  4. Study sites: 1 to 4v3
  5. Start date: Dec 1, 2024 to Feb 15, 2025v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to compare whether the FDA and Health Canada approved microUS is as effective as the currently used option (MRI) for imaging the prostate gland. Participants will be randomized into two groups to compare the imaging results of the current standard of care MRI and the new microUS. The study is looking to identify the most effective imaging modality to help guide whether you progress to have a prostate biopsy.
Trial Details
NCT Number NCT06626022
Lead Sponsor University of Alberta
Conditions
(from sponsor)		 Prostate Cancer Screening
Enrollment 1,284 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov